EAM
FPRX
Eventide Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-105,000
| Closed | -$1.8M | – | 152 |
|
|
2018
Q1 | $1.8M | Sell |
105,000
-210,000
| -67% | -$3.61M | 0.08% | 118 |
|
|
2017
Q4 | $6.91M | Sell |
315,000
-286,000
| -48% | -$6.27M | 0.36% | 74 |
|
|
2017
Q3 | $24.6M | Hold |
601,000
| – | – | 1.39% | 28 |
|
|
2017
Q2 | $18.1M | Hold |
601,000
| – | – | 1.13% | 40 |
|
|
2017
Q1 | $21.7M | Sell |
601,000
-209,000
| -26% | -$7.56M | 1.44% | 29 |
|
|
2016
Q4 | $40.6M | Sell |
810,000
-205,200
| -20% | -$10.3M | 2.64% | 5 |
|
|
2016
Q3 | $53.3M | Sell |
1,015,200
-70,000
| -6% | -$3.67M | 3.25% | 2 |
|
|
2016
Q2 | $44.9M | Sell |
1,085,200
-70,000
| -6% | -$2.89M | 2.75% | 7 |
|
|
2016
Q1 | $46.9M | Sell |
1,155,200
-100,000
| -8% | -$4.06M | 2.62% | 9 |
|
|
2015
Q4 | $52.1M | Buy |
1,255,200
+90,300
| +8% | +$3.75M | 2.6% | 6 |
|
|
2015
Q3 | $17.9M | Buy |
1,164,900
+207,000
| +22% | +$3.19M | 1.04% | 39 |
|
|
2015
Q2 | $23.8M | Buy |
957,900
+118,500
| +14% | +$2.94M | 1.29% | 30 |
|
|
2015
Q1 | $19.2M | Buy |
839,400
+55,400
| +7% | +$1.27M | 1.44% | 29 |
|
|
2014
Q4 | $21.2M | Buy |
784,000
+10,400
| +1% | +$281K | 2.31% | 9 |
|
|
2014
Q3 | $9.07M | Hold |
773,600
| – | – | 1.27% | 37 |
|
|
2014
Q2 | $12M | Buy |
773,600
+260,400
| +51% | +$4.05M | 1.64% | 21 |
|
|
2014
Q1 | $10.1M | Buy |
+513,200
| New | +$10.1M | 1.57% | 25 |
|